{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:48:00Z","timestamp":1778078880792,"version":"3.51.4"},"reference-count":126,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T00:00:00Z","timestamp":1621641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K08313"],"award-info":[{"award-number":["21K08313"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K08337"],"award-info":[{"award-number":["21K08337"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.alit.2021.05.005","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T08:52:50Z","timestamp":1623401570000},"page":"421-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Alarmins\/stressorins and immune dysregulation in intractable skin disorders"],"prefix":"10.1016","volume":"70","author":[{"given":"Kiyofumi","family":"Yamanishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutomo","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2021.05.005_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.coi.2005.06.002","article-title":"Alarmins: chemotactic activators of immune responses","volume":"17","author":"Oppenheim","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri1372","article-title":"Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses","volume":"4","author":"Seong","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/imr.12577","article-title":"Alarmins and immunity","volume":"280","author":"Yang","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.alit.2021.05.005_bib4","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4049\/jimmunol.1601342","article-title":"Alarmins: feel the stress","volume":"198","author":"Rider","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib5","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/bjd.18420","article-title":"Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel","volume":"182","author":"Schaller","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib6","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2013.04.043","article-title":"Rosacea: current state of epidemiology","volume":"69","author":"Tan","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib7","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","article-title":"Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors","volume":"72","author":"Two","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/exd.13143","article-title":"Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics","volume":"26","author":"Holmes","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2020.02.025","article-title":"Rosacea is characterized by a profoundly diminished skin barrier","volume":"140","author":"Medgyesi","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib10","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/exd.12030","article-title":"Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation","volume":"21","author":"Casas","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2133.2007.08028.x","article-title":"Mite-related bacterial antigens stimulate inflammatory cells in rosacea","volume":"157","author":"Lacey","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib12","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1365-2133.2012.11114.x","article-title":"Positive correlation between serum immunoreactivity to Demodex-associated Bacillus proteins and erythematotelangiectatic rosacea","volume":"167","author":"O'Reilly","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.alit.2021.05.005_bib14","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/jid.2010.351","article-title":"TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes","volume":"131","author":"Yamasaki","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib15","doi-asserted-by":"crossref","first-page":"E1334","DOI":"10.1073\/pnas.1504555113","article-title":"ER stress stimulates production of the key antimicrobial peptide, cathelicidin, by forming a previously unidentified intracellular S1P signaling complex","volume":"113","author":"Park","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.alit.2021.05.005_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2019.08.436","article-title":"Innate immune dysfunction in rosacea promotes photosensitivity and vascular adhesion molecule expression","volume":"140","author":"Kulkarni","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib17","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.4049\/jimmunol.170.5.2274","article-title":"Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide","volume":"170","author":"Di Nardo","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jidsymp.2011.6","article-title":"Neurovascular and neuroimmune aspects in the pathophysiology of rosacea","volume":"15","author":"Schwab","year":"2011","journal-title":"J\u00a0Investig Dermatol Symp Proc"},{"key":"10.1016\/j.alit.2021.05.005_bib19","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/jid.2014.222","article-title":"Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea","volume":"134","author":"Muto","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/72247","article-title":"Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism","volume":"6","author":"Steinhoff","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.alit.2021.05.005_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.jid.5700965","article-title":"Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases","volume":"128","author":"Stefansson","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-0625.1999.tb00383.x","article-title":"Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase","volume":"8","author":"Steinhoff","year":"1999","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1346-8138.2011.01462.x","article-title":"Interleukin-17- and protease-activated receptor 2-mediated production of CXCL1 and CXCL8 modulated by cyclosporine A, vitamin D3 and glucocorticoids in human keratinocytes","volume":"39","author":"Takei-Taniguchi","year":"2012","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib24","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jid.2018.01.034","article-title":"Major role for TRPV1 and InsP3R in PAR2-elicited inflammatory mediator production in differentiated human keratinocytes","volume":"138","author":"Gouin","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib25","doi-asserted-by":"crossref","first-page":"13875","DOI":"10.1074\/jbc.M115.642736","article-title":"Neutrophil elastase activates protease-activated receptor-2 (PAR2) and transient receptor potential vanilloid 4 (TRPV4) to cause inflammation and pain","volume":"290","author":"Zhao","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.alit.2021.05.005_bib26","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jid.2016.10.046","article-title":"TRPV4 mediates mast cell activation in cathelicidin-induced rosacea inflammation","volume":"137","author":"Mascarenhas","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib27","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/jdv.14402","article-title":"Systemic therapy of ocular and cutaneous rosacea in children","volume":"31","author":"Gonser","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.alit.2021.05.005_bib28","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1128\/AAC.00140-07","article-title":"Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytes","volume":"52","author":"Tsuda","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.alit.2021.05.005_bib29","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1128\/AAC.01540-08","article-title":"Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes","volume":"53","author":"Ishikawa","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.alit.2021.05.005_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A\u00a0systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.alit.2021.05.005_bib31","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.alit.2021.05.005_bib32","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2021.05.005_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","article-title":"Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies","volume":"80","author":"Alinaghi","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib34","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nrrheum.2009.210","article-title":"The diagnosis and treatment of early psoriatic arthritis","volume":"5","author":"Anandarajah","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.alit.2021.05.005_bib35","first-page":"S2","article-title":"Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine","volume":"33","author":"Alwan","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.alit.2021.05.005_bib36","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib37","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/43088","article-title":"A\u00a0peptide antibiotic from human skin","volume":"387","author":"Harder","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.alit.2021.05.005_bib38","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1189\/jlb.0704409","article-title":"Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins","volume":"77","author":"Harder","year":"2005","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.alit.2021.05.005_bib39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0014-4800(02)00023-0","article-title":"In human epidermis, beta-defensin 2 is packaged in lamellar bodies","volume":"74","author":"Oren","year":"2003","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.alit.2021.05.005_bib40","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.4049\/jimmunol.171.6.3262","article-title":"Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes","volume":"171","author":"Nomura","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib42","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2016.06.038","article-title":"Beta-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis","volume":"139","author":"Kolbinger","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib43","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.alit.2021.05.005_bib44","doi-asserted-by":"crossref","first-page":"7028","DOI":"10.1074\/jbc.M109.091090","article-title":"Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells","volume":"285","author":"R\u00f6hrl","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.alit.2021.05.005_bib45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/jid.2012.260","article-title":"CCR6 is required for epidermal trafficking of gamma-delta-T cells in an IL-23-induced model of psoriasiform dermatitis","volume":"133","author":"Mabuchi","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.03.035","article-title":"The antimicrobial peptide human beta-defensin 2 promotes itch through Toll-like receptor 4 signaling in mice","volume":"140","author":"Feng","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib47","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.0022-202X.2004.23443.x","article-title":"Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies","volume":"124","author":"Braff","year":"2005","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib48","doi-asserted-by":"crossref","first-page":"15258","DOI":"10.1074\/jbc.272.24.15258","article-title":"The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders","volume":"272","author":"Frohm","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.alit.2021.05.005_bib49","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.alit.2021.05.005_bib50","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20090480","article-title":"Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8","volume":"206","author":"Ganguly","year":"2009","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.alit.2021.05.005_bib51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41467-019-13756-4","article-title":"Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis","volume":"11","author":"Herster","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.alit.2021.05.005_bib52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.alit.2021.05.005_bib53","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4049\/jimmunol.1201648","article-title":"beta-Defensin 2 and 3 promote the uptake of self or CpG DNA, enhance IFN-alpha production by human plasmacytoid dendritic cells, and promote inflammation","volume":"191","author":"Tewary","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib54","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"5","author":"Lande","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.alit.2021.05.005_bib55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2021.05.005_bib56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1346-8138.2012.01504.x","article-title":"Current understanding of human genetics and genetic analysis of psoriasis","volume":"39","author":"Oka","year":"2012","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib57","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jid.2016.04.033","article-title":"Binding affinity and interaction of LL-37 with HLA-C\u221706:02 in psoriasis","volume":"136","author":"Mabuchi","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/cmi.2016.34","article-title":"HMGB1, IL-1alpha, IL-33 and S100 proteins: dual-function alarmins","volume":"14","author":"Bertheloot","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib59","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/156652413804486214","article-title":"Functions of S100 proteins","volume":"13","author":"Donato","year":"2013","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.alit.2021.05.005_bib60","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/1523-1747.ep12338501","article-title":"Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex (\"epidermal differentiation complex\") on human chromosome 1q21","volume":"106","author":"Mischke","year":"1996","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib61","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/1523-1747.ep12484041","article-title":"Molecular cloning, occurrence, and expression of a novel partially secreted protein \u201cpsoriasin\u201d that is highly up-regulated in psoriatic skin","volume":"97","author":"Madsen","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib62","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1046\/j.1523-1747.2000.00005-2.x","article-title":"Calgranulin C is overexpressed in lesional psoriasis","volume":"114","author":"Mirmohammadsadegh","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib63","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/002215540305100513","article-title":"S100 protein subcellular localization during epidermal differentiation and psoriasis","volume":"51","author":"Broome","year":"2003","journal-title":"J\u00a0Histochem Cytochem"},{"key":"10.1016\/j.alit.2021.05.005_bib64","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2133.2006.07198.x","article-title":"Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis","volume":"155","author":"Benoit","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib65","doi-asserted-by":"crossref","first-page":"61ra90","DOI":"10.1126\/scitranslmed.3001108","article-title":"Gene from a psoriasis susceptibility locus primes the skin for inflammation","volume":"2","author":"Wolf","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.alit.2021.05.005_bib66","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaad.2010.02.049","article-title":"Markedly elevated serum levels of calcium-binding S100A8\/A9 proteins in psoriatic arthritis are due to activated monocytes\/macrophages","volume":"64","author":"Aochi","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib67","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/MCB.23.3.1034-1043.2003","article-title":"Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in\u00a0vitro","volume":"23","author":"Manitz","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.alit.2021.05.005_bib68","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/jcb.21639","article-title":"S100A8\/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes","volume":"104","author":"Nukui","year":"2008","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.alit.2021.05.005_bib69","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1189\/jlb.0607397","article-title":"S100A8\/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway","volume":"83","author":"Ghavami","year":"2008","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.alit.2021.05.005_bib70","doi-asserted-by":"crossref","first-page":"23389","DOI":"10.1074\/jbc.M114.573071","article-title":"DNAX-activating protein 10 (DAP10) membrane adaptor associates with receptor for advanced glycation end products (RAGE) and modulates the RAGE-triggered signaling pathway in human keratinocytes","volume":"289","author":"Sakaguchi","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.alit.2021.05.005_bib71","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.alit.2021.05.005_bib72","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature03963","article-title":"Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins","volume":"437","author":"Zenz","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.alit.2021.05.005_bib73","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4049\/jimmunol.2000087","article-title":"Deletion of S100a8 and S100a9 enhances skin hyperplasia and promotes the Th17 response in imiquimod-induced psoriasis","volume":"206","author":"Defr\u00eane","year":"2021","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib74","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2133.2008.08904.x","article-title":"Detection of psoriasin\/S100A7 in the sera of patients with psoriasis","volume":"160","author":"Anderson","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib75","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/jdv.13269","article-title":"Among the S100 proteins, S100A12 is the most significant marker for psoriasis disease activity","volume":"30","author":"Wilsmann-Theis","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.alit.2021.05.005_bib76","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/art.10988","article-title":"Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis","volume":"48","author":"Kane","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.alit.2021.05.005_bib77","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/all.12619","article-title":"Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities","volume":"70","author":"Mortz","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2021.05.005_bib78","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jid.2016.07.012","article-title":"The burden of atopic dermatitis: summary of a report for the National Eczema Association","volume":"137","author":"Drucker","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib79","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jid.2020.07.006","article-title":"Which way do we go? Complex interactions in atopic dermatitis pathogenesis","volume":"141","author":"Patrick","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib80","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jaci.2014.06.014","article-title":"Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis","volume":"134","author":"Thyssen","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib81","doi-asserted-by":"crossref","first-page":"158673","DOI":"10.1016\/j.bbalip.2020.158673","article-title":"Skin of atopic dermatitis patients shows disturbed beta-glucocerebrosidase and acid sphingomyelinase activity that relates to changes in stratum corneum lipid composition","volume":"1865","author":"Boer","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.alit.2021.05.005_bib82","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib83","doi-asserted-by":"crossref","first-page":"eaah4680","DOI":"10.1126\/scitranslmed.aah4680","article-title":"Antimicrobials from human skin commensal bacteria protect against","volume":"9","author":"Nakatsuji","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.alit.2021.05.005_bib84","article-title":"Events in normal skin promote early-life atopic dermatitis-The MPAACH Cohort","volume":"8","author":"Biagini Myers","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2021.05.005_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib86","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jaci.2020.02.008","article-title":"Reconciling innate and acquired immunity in atopic dermatitis","volume":"145","author":"Honda","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib87","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/all.12932","article-title":"Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic review","volume":"71","author":"Tam","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2021.05.005_bib88","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.it.2020.11.006","article-title":"Early events triggering the initiation of a type 2 immune response","volume":"42","author":"El-Naccache","year":"2021","journal-title":"Trends Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib89","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2021.05.005_bib90","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/jid.2011.446","article-title":"IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors","volume":"132","author":"Savinko","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib91","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2014.02.012","article-title":"Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation","volume":"55","author":"Bessa","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.alit.2021.05.005_bib92","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.jid.2017.03.042","article-title":"House dust mite increases pro-Th2 cytokines IL-25 and IL-33 via the activation of TLR1\/6 signaling","volume":"137","author":"Jang","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib93","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jaci.2020.09.023","article-title":"Staphylococcus aureus second immunoglobulin-binding protein drives atopic dermatitis via IL-33","volume":"147","author":"Al Kindi","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib94","doi-asserted-by":"crossref","first-page":"165719","DOI":"10.1016\/j.bbadis.2020.165719","article-title":"House dust mite allergens induce interleukin 33 (IL-33) synthesis and release from keratinocytes via ATP-mediated extracellular signaling","volume":"1866","author":"Dai","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.alit.2021.05.005_bib95","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41590-018-0067-5","article-title":"Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33","volume":"19","author":"Cayrol","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib96","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.alit.2021.05.005_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.01.048","article-title":"IL-33 impacts on the skin barrier by downregulating the expression of filaggrin","volume":"135","author":"Seltmann","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib98","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jdermsci.2018.02.017","article-title":"IL-33 down-regulates CLDN1 expression through the ERK\/STAT3 pathway in keratinocytes","volume":"90","author":"Ryu","year":"2018","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.alit.2021.05.005_bib99","doi-asserted-by":"crossref","first-page":"13921","DOI":"10.1073\/pnas.1307321110","article-title":"Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice","volume":"110","author":"Imai","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.alit.2021.05.005_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2019.04.016","article-title":"IL-33-induced atopic dermatitis-like inflammation in mice is mediated by group 2 innate lymphoid cells in concert with basophils","volume":"139","author":"Imai","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib101","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1084\/jem.20130351","article-title":"A\u00a0role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.alit.2021.05.005_bib102","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jamadermatol.2019.2983","article-title":"Use of tape strips to detect immune and barrier abnormalities in the skin of children with early-onset atopic dermatitis","volume":"155","author":"Guttman-Yassky","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib103","first-page":"100003","article-title":"Dupilumab effects on innate lymphoid cell and Th cell populations in patients with atopic dermatitis","volume":"1","author":"Imai","year":"2021","journal-title":"J\u00a0Invest Dermatol Innov"},{"key":"10.1016\/j.alit.2021.05.005_bib104","doi-asserted-by":"crossref","first-page":"eaax2945","DOI":"10.1126\/scitranslmed.aax2945","article-title":"Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis","volume":"11","author":"Chen","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.alit.2021.05.005_bib105","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1073\/pnas.95.3.1044","article-title":"Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase)","volume":"95","author":"Matsuki","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.alit.2021.05.005_bib106","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1172\/JCI0213563","article-title":"Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1","volume":"109","author":"Kuramoto","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.alit.2021.05.005_bib107","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jdermsci.2011.12.011","article-title":"Knocking-in the R142C mutation in transglutaminase 1 disrupts the stratum corneum barrier and postnatal survival of mice","volume":"65","author":"Nakagawa","year":"2012","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.alit.2021.05.005_bib108","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ng0395-279","article-title":"Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis","volume":"9","author":"Russell","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.alit.2021.05.005_bib109","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1086\/515498","article-title":"Transglutaminase 1 mutations in autosomal recessive congenital ichthyosis: private and recurrent mutations in an isolated population","volume":"61","author":"Laiho","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.alit.2021.05.005_bib110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2133.2011.10594.x","article-title":"Bathing suit ichthyosis with summer exacerbation: a temperature-sensitive case","volume":"166","author":"Yamamoto","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib111","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/1346-8138.12846","article-title":"Lamellar ichthyosis with pseudoexon activation in the transglutaminase 1 gene","volume":"42","author":"Suga","year":"2015","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib112","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1093\/hmg\/ddq145","article-title":"Interleukin-1 alpha blockade prevents hyperkeratosis in an in\u00a0vitro model of lamellar ichthyosis","volume":"19","author":"O'Shaughnessy","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.alit.2021.05.005_bib113","doi-asserted-by":"crossref","first-page":"e0159673","DOI":"10.1371\/journal.pone.0159673","article-title":"Activation of molecular signatures for antimicrobial and innate defense responses in skin with transglutaminase 1 deficiency","volume":"11","author":"Haneda","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2021.05.005_bib114","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1111\/1346-8138.13976","article-title":"Mild case of congenital ichthyosiform erythroderma with periodic exacerbation: novel mutations in ABCA12 and upregulation of calprotectin in the epidermis","volume":"44","author":"Wada","year":"2017","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib115","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1111\/1346-8138.14781","article-title":"Japanese case of Mal de Meleda with a novel missense mutation of p.Thr52Ala in the second protruding finger of secreted Ly-6\/uPAR-related protein 1","volume":"46","author":"Kunisada","year":"2019","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib116","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaci.2018.03.021","article-title":"Ichthyosis molecular fingerprinting shows profound T","volume":"143","author":"Malik","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.05.005_bib117","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/75977","article-title":"Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome","volume":"25","author":"Chavanas","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.alit.2021.05.005_bib118","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/sj.jid.5700284","article-title":"Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome","volume":"126","author":"Descargues","year":"2006","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib119","doi-asserted-by":"crossref","first-page":"e1006566","DOI":"10.1371\/journal.pgen.1006566","article-title":"KLK5 and KLK7 ablation fully rescues lethality of Netherton syndrome-like phenotype","volume":"13","author":"Kasparek","year":"2017","journal-title":"Plos Genet"},{"key":"10.1016\/j.alit.2021.05.005_bib120","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1038\/jid.2010.233","article-title":"Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model","volume":"130","author":"Briot","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib121","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/1346-8138.12410","article-title":"Upregulation of interleukin-33 in the epidermis of two Japanese patients with Netherton syndrome","volume":"41","author":"Konishi","year":"2014","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib122","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/1346-8138.13090","article-title":"Severe lethal phenotype of a Japanese case of Netherton syndrome with homozygous founder mutations of SPINK5 c.375_376delAT","volume":"42","author":"Itoh","year":"2015","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib123","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/jamadermatol.2020.1019","article-title":"Secukinumab therapy for Netherton syndrome","volume":"156","author":"Luchsinger","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib124","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jdcr.2020.04.025","article-title":"Successful use of secukinumab in Netherton syndrome","volume":"6","author":"Blanchard","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.alit.2021.05.005_bib125","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/ced.14317","article-title":"Successful treatment with dupilumab of an adult with Netherton syndrome","volume":"45","author":"Andreasen","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.alit.2021.05.005_bib126","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/pde.14362","article-title":"Netherton syndrome: temporary response to dupilumab","volume":"37","author":"Aktas","year":"2020","journal-title":"Pediatr Dermatol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S132389302100054X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S132389302100054X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:11:10Z","timestamp":1761156670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S132389302100054X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":126,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S132389302100054X"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2021.05.005","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alarmins\/stressorins and immune dysregulation in intractable skin disorders","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2021.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}